logo
Sign in

SNANF Stock Price, Chart, Stats & News

Sona Nanotech Inc.
Save

Sona Nanotech Inc. (SNANF) does not currently pay a dividend.

29.74M
Market cap
–
Current P/E
–
Forward P/E

SNANF chart

About

Health care
Sector
Biotechnology
Industry

Sona Nanotech Inc. is a life sciences enterprise specializing in nanotechnology, primarily engaged in the development and commercialization of gold nanorod products for diagnostic purposes. The company's offerings also encompass distinct gold nanorod varieties, such as Gemini and Omni (the latter tailored specifically for medical uses), alongside providing specialized contract services. A prominent product is their Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic test designed to identify SARS-CoV-2 spike protein antigens within saliva samples from individuals suspected of COVID-19 infection.

Similar securities

Based on sector and market capitalization

Report issue